Paris Colon Cancer Congress 2026

Julien Taieb – France

Julien Taieb is a professor of gastroenterology and gastrointestinal oncology at Université Paris Cité and Head of the Gastroenterology and Gastrointestinal Oncology Department at Georges Pompidou European Hospital in Paris, France. His work focuses on colorectal and pancreatic cancers, with particular expertise in clinical trials, translational research, biomarkers, and precision oncology.

Annalice Gandini – France

Annalice Gandini is a medical oncologist and doctoral researcher at the Centre de Recherche des Cordeliers and Hôpital Européen Georges-Pompidou in Paris, France. She is pursuing a PhD in Integrative and Translational Biology at Université Paris Cité, focusing on gastrointestinal cancers. Her research interests include colorectal cancer, immunotherapy, biomarkers, and precision oncology.

Amalya Sargsyan – Armenia

Amalya Sargsyan is a medical oncologist at the Yeolyan Hematology and Oncology Center and Head of the Sarcoma Service at D’Clinic in Armenia. She also serves as Vice President of Research and Intelligence at OncoDaily, where she leads research initiatives and advances evidence-based oncology communication.

Francisco Javier Ros – Spain

Dr. Francisco Javier Ros is a medical oncologist and clinical investigator in Barcelona, Spain, specializing in colorectal cancer. He practices at Vall d’Hebron University Hospital and the IOB Institute of Oncology and is a member of VHIO’s Gastrointestinal Tract Tumours Group. His research focuses on precision oncology, biomarkers, and targeted therapies for colorectal cancer.

Claire Gallois – France

Claire Gallois, is a Gastroenterologist and Digestive Oncologist at Hôpital Européen Georges-Pompidou, AP-HP, and Université Paris Cité in Paris, France. Her clinical and research interests focus on gastrointestinal malignancies, particularly colorectal cancer, molecular profiling, biomarkers, and precision oncology.

Jenny Seligmann – United Kingdom

Jenny Seligmann is Professor of Gastrointestinal and Translational Oncology at the University of Leeds and an Honorary Consultant Medical Oncologist at Leeds Teaching Hospitals NHS Trust, UK. Her clinical and research interests focus on colorectal cancer, neoadjuvant treatment, biomarkers, personalized therapy, and clinical trials. She leads major international bowel cancer studies, including the FOxTROT programme.

Michel Ducreux – France

Michel Ducreux, is Professor of Medical Oncology and Head of the Gastrointestinal Oncology Unit and Gastrointestinal Tumor Board at Gustave Roussy in Villejuif, France. His clinical and research expertise focuses on gastrointestinal malignancies, particularly colorectal cancer, pancreatic cancer, biomarker-driven oncology, and international clinical trials.

Airazat Kazaryan – Norway

Airazat Kazaryan, is a Consultant Surgeon in the Department of Gastrointestinal Surgery at Østfold Hospital Trust, Norway, and an Honorary Researcher at Oslo University Hospital. His clinical and research interests focus on gastrointestinal and colorectal surgery, minimally invasive surgery, colorectal liver metastases, hepatopancreatobiliary surgery, surgical oncology, and surgical outcomes.

Eric Van Cutsem – Belgium

Eric Van Cutsem, is Professor Emeritus with formal duties at KU Leuven, Belgium, and an internationally recognized expert in gastrointestinal oncology. His clinical and research work has focused on colorectal and other digestive cancers, precision oncology, biomarkers, clinical trials, and the development of new treatment strategies.

Gertjan Rasschaert – Belgium

Gertjan Rasschaert is a Gastroenterologist and Digestive Oncologist at UZ Leuven, Belgium, and is involved in colorectal cancer research at KU Leuven. His clinical and research interests focus on colon and rectal cancer, neoadjuvant treatment, immunotherapy in pMMR/MSS colorectal cancer, response prediction, and translational research.

Sabine Tejpar – Belgium

Sabine Tejpar is a Professor, Gastroenterologist, and Digestive Oncologist at KU Leuven and UZ Leuven, Belgium. She leads Digestive Oncology and research in the molecular genetics of colorectal tumors. Her work focuses on colorectal cancer biology, molecular subtyping, biomarkers, organoid models, precision oncology, and translating laboratory discoveries into clinical trials.

Yelena Y. Janjigian – United States , New York

Yelena Y. Janjigian, is a gastrointestinal medical oncologist at Memorial Sloan Kettering Cancer Center in New York. Her clinical and research expertise focuses on gastrointestinal cancers, particularly gastric and esophageal cancers, as well as targeted therapies, immunotherapy, and precision oncology.

The Paris Colon Cancer Congress 2026 (P3C) is an international congress focused on advancing multidisciplinary and patient-centered colorectal cancer care. The program will cover early-onset, localized, and metastatic disease, immunotherapy, biomarkers, treatment sequencing, survivorship, quality of life, equity, and access to care.

Through expert sessions, clinical debates, multidisciplinary discussions, and patient perspectives, P3C aims to support practical strategies that improve colorectal cancer care and outcomes worldwide.

Who Should Attend?

P3C is designed for oncologists, surgeons, gastroenterologists, pathologists, researchers, oncology nurses, pharmacists, patient advocates, healthcare leaders, and other professionals involved in colorectal cancer care and research.

Why To Attend?

Participants will gain practical insights into current standards, emerging evidence, and challenging areas of colorectal cancer management. The congress will also offer opportunities to learn from international experts, multidisciplinary teams, and patient representatives.

Partnership & Collaboration Opportunities
Shushan Hovsepyan
Senior Vice President, OncoDaily
Email: shushan.hovsepyan@oncodaily.com
Phone: +1 571 775 9710

Event-Related Inquiries
Inessa Mkhitaryan
Head of Global Events, OncoDaily
Email: inessa.mkhitaryan@oncodaily.com

General Inquiries
Email: info@oncodaily.com